Clinical Trials · NCT03010475
A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 41
- Start date
- Jan 2017
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Area under the furosemide plasma concentration-time curve